Free Trial
LON:4BB

4basebio (4BB) Share Price, News & Analysis

4basebio logo
GBX 1,100.50 -24.50 (-2.18%)
As of 06:06 AM Eastern

About 4basebio Stock (LON:4BB)

Key Stats

Today's Range
1,100.50
1,143
50-Day Range
1,092
1,205
52-Week Range
1,090
1,820
Volume
348 shs
Average Volume
958 shs
Market Capitalization
£140.97 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
GBX 1,600
Consensus Rating
Buy

Company Overview

4basebio is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients. Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients. These products and technologies are also available for customers and partners with whom we endeavor to combine our capabilities and know-how to develop gene therapy solutions for clinical development and commercialisation.

4basebio Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
31st Percentile Overall Score

4BB MarketRank™: 

4basebio scored higher than 31% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    4basebio has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    4basebio has only been the subject of 1 research reports in the past 90 days.

  • Read more about 4basebio's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of 4basebio is -1,410.90, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of 4basebio is -1,410.90, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Short Interest

    There is no current short interest data available for 4BB.
  • Dividend Yield

    4basebio does not currently pay a dividend.

  • Dividend Growth

    4basebio does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for 4BB.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for 4basebio this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, 4basebio insiders have bought more of their company's stock than they have sold. Specifically, they have bought £41,811.20 in company stock and sold GBX 0 in company stock.

  • Percentage Held by Insiders

    68.44% of the stock of 4basebio is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 2.04% of the stock of 4basebio is held by institutions.

  • Read more about 4basebio's insider trading history.
Receive 4BB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 4basebio and its competitors with MarketBeat's FREE daily newsletter.

4BB Stock News Headlines

4basebio Plc - Director Dealing
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
4basebio UK Societas (4BB) Gets a Buy from RBC Capital
See More Headlines

4BB Stock Analysis - Frequently Asked Questions

4basebio's stock was trading at GBX 1,210 on January 1st, 2025. Since then, 4BB shares have decreased by 9.0% and is now trading at GBX 1,100.50.
View the best growth stocks for 2025 here
.

Shares of 4BB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that 4basebio investors own include B&M European Value Retail (BME), Coats Group (COA), 4D pharma (DDDD), genedrive (GDR), Greencore Group (GNC), IQE (IQE) and Omega Diagnostics Group (ODX).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:4BB
CIK
N/A
Fax
N/A
Employees
101
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
GBX 1,600
High Stock Price Target
GBX 1,600
Low Stock Price Target
GBX 1,600
Potential Upside/Downside
+45.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
£-9,840,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£311,000.00
Cash Flow
GBX 68.44 per share
Price / Cash Flow
16.08
Book Value
GBX (41) per share
Price / Book
-26.84

Miscellaneous

Free Float
N/A
Market Cap
£140.97 million
Optionable
Not Optionable
Beta
1.09
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (LON:4BB) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners